1. Home
  2. TLF vs TVGN Comparison

TLF vs TVGN Comparison

Compare TLF & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tandy Leather Factory Inc.

TLF

Tandy Leather Factory Inc.

N/A

Current Price

$2.54

Market Cap

19.5M

ML Signal

N/A

Logo Tevogen Bio Holdings Inc.

TVGN

Tevogen Bio Holdings Inc.

N/A

Current Price

$6.57

Market Cap

21.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
TLF
TVGN
Founded
1980
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Apparel
Blank Checks
Sector
Consumer Discretionary
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
19.5M
21.3M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
TLF
TVGN
Price
$2.54
$6.57
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 11.5K
7.7K
Earning Date
11-09-2026
11-13-2026
Dividend Yield
★ 30.07%
N/A
EPS Growth
★ 1122.22
N/A
EPS
★ 0.08
N/A
Revenue
★ $76,324,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$31.50
★ N/A
Revenue Growth
★ 2.60
N/A
52 Week Low
$2.20
$0.14
52 Week High
$3.36
$12.03

Technical Indicators

Market Signals
Indicator
TLF
TVGN
Relative Strength Index (RSI) 46.48 38.51
Support Level $2.52 $6.22
Resistance Level $2.69 $7.72
Average True Range (ATR) 0.13 0.53
MACD -0.02 -0.16
Stochastic Oscillator 15.20 11.61

Price Performance

Historical Comparison
TLF
TVGN

About TLF Tandy Leather Factory Inc.

Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, and Canada. it generates the highest revenue from the United States.

About TVGN Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.

Share on Social Networks: